Clustered nanobody-drug conjugates for targeted cancer therapy

被引：18
|
作者：
Wu, Tiantian [1 ]
Liu, Manman [1 ]
Huang, Hai [1 ]
Sheng, Yaping [1 ]
Xiao, Haihua [2 ]
Liu, Yangzhong [1 ]
机构：
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Life Sci & Med, Dept Chem, Hefei 230001, Anhui, Peoples R China
[2] Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, State Key Lab Polymer Phys & Chem, Beijing 100190, Peoples R China
来源：
CHEMICAL COMMUNICATIONS | 2020年 / 56卷 / 65期
基金：
美国国家科学基金会; 国家重点研发计划;
关键词：
EGFR; PEGYLATION; DELIVERY; SITE;
D O I：
10.1039/d0cc03396k
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
A clustered Nb-drug conjugate (cNDC@PEG) was designed using anti-EGFR Nb to specifically deliver Pt(iv) prodrugs to tumors. cNDC@PEG efficiently targets EGFR positive tumor cells, and the clustered cNDC@PEG is more efficient in inhibiting tumor growthin vivothan the monomeric NDC. This work provides a novel strategy for the construction of a multi-valent NDC using dendrimers.
引用
收藏
页码：9344 / 9347
页数：4
相关论文
共 50 条
  • [41] Bispecific antibody complex pre-targeting and targeted delivery of polymer drug conjugates for imaging and therapy in dual human mammary cancer xenograftsTargeted polymer drug conjugates for cancer diagnosis and therapy
    Ban-An Khaw
    Keyur S. Gada
    Vishwesh Patil
    Rajiv Panwar
    Savitri Mandapati
    Arash Hatefi
    Stan Majewski
    Andrew Weisenberger
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1603 - 1616
  • [42] Antibody-Drug Conjugates for Cancer Therapy
    Hafeez, Umbreen
    Parakh, Sagun
    Gan, Hui K.
    Scott, Andrew M.
    MOLECULES, 2020, 25 (20):
  • [43] Potent antibody drug conjugates for cancer therapy
    Senter, Peter D.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2009, 13 (03) : 235 - 244
  • [44] Peptide Drug Conjugates and Their Role in Cancer Therapy
    Heh, Ethan
    Allen, Jesse
    Ramirez, Fabiola
    Lovasz, Daniel
    Fernandez, Lorena
    Hogg, Tanis
    Riva, Hannah
    Holland, Nathan
    Chacon, Jessica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [45] Antibody-drug conjugates for cancer therapy
    Carter, Paul J.
    Senter, Peter D.
    CANCER JOURNAL, 2008, 14 (03): : 154 - 169
  • [46] Antibody-Drug Conjugates for Cancer Therapy
    Parslow, Adam C.
    Parakh, Sagun
    Lee, Fook-Thean
    Gan, Hui K.
    Scott, Andrew M.
    BIOMEDICINES, 2016, 4 (03)
  • [47] Antibody-Drug Conjugates in Cancer Therapy
    Sievers, Eric L.
    Senter, Peter D.
    ANNUAL REVIEW OF MEDICINE, VOL 64, 2013, 64 : 15 - 29
  • [48] Raptamer-drug conjugates as molecularly targeted cancer therapeutics
    Vega, Stephanie P.
    Ward, Nancy E.
    Saini, Uksha
    Castan-Chibas, Leniher
    Kaushik, Garima
    Ciznadija, Daniel
    Chatterjee, Dev
    Heffernan, Michael J.
    Varadhachary, Atul
    Ritchie, Michael
    CANCER RESEARCH, 2024, 84 (06)
  • [49] Raptamer-drug conjugates as molecularly targeted cancer therapeutics
    Vega, Stephanie P.
    Chatterjee, Dev
    Varadhachary, Atul
    Ritchie, Michael
    Heffernan, Michael
    Ciznadija, Daniel
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Trends in cancer-targeted antibody-drug conjugates
    Bidard, Francois-Clement
    Tredan, Olivier
    TARGETED ONCOLOGY, 2014, 9 (01) : 1 - 8
12345